Hostname: page-component-78c5997874-94fs2 Total loading time: 0 Render date: 2024-11-09T22:47:07.558Z Has data issue: false hasContentIssue false

Integrated Therapy for Mental and Behavioural Disorders Due to Use of Cannabinoids

Published online by Cambridge University Press:  15 April 2020

I. Sosin
Affiliation:
Narcology, Kharkov medical academy of postgraduate education, Kharkov, Ukraine
Y.U. Chuev
Affiliation:
Narcology, Kharkov medical academy of postgraduate education, Kharkov, Ukraine
E. Goncharova
Affiliation:
Narcology, Kharkov medical academy of postgraduate education, Kharkov, Ukraine

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

High prevalence of mental and behavioural disorders at cannabinoid pathological dependence in population, highrisk of comorbid diseases development, absence ofeffective methods for pathogenetic treatment determine topicality of thisaddictive disease.

Currently, specific clinical manifestations of discontinuation syndrome, changedreactivity (tolerance), differentsomatic vegetative disorders, presenceof subject dreams, pathognomonicliver lesions are important clinical markers of hashishdependence. Impulse actualization periods are accompanied with functional deviations in cerebral haemodynamics aspathophysiological ground for abstinent disorders and recurrencies of thedisease.

We have elaborated and tested in 35 cannabinoid addicts the integrated treatmentalgorithm which combines: 1) stopping of cessasion syndromewith detoxication membrane plasmapheresis and plasma exfusion of800-1000 ml, course of 2-3 procedures; 2) using new generationhepatoprotectors ”L'esfal“ (5.0 ml intravenously, oncedaily, 5-10 injections course) and ”Antral“(0.2 g tablets perorally 3 times daily, 3-4-week course); 3) anticraving method withinnovative autotraining computer system ?iofeedback – psychophysiologicalbio-adaptive system regulation: 7-10 sessions during which the patient uses specialtraining recommendations in autoregulation of physiological and pathologicallychanged body functions and acquires the skills of independent suppression ofcannabinoid smoking addiction; 4) psychotherapeutic mediation procedure for the presentvisual signs of toxic metabolic (xenobiotic) post-intoxication contamination ofplasma excreted and collected at plasmapheresis aimed to target anticraving ofrespondent's cognitive frustration.

Method was carried out to minimizebackground standard symptomatic pharmacotherapy. High efficiencyof the proposed complex has been proved on the ground of clinicalpsychopathological, pathopsychological testing, computedelectroencephalography and rheoencephalography as well as biochemical studies.

Type
Article: 1061
Copyright
Copyright © European Psychiatric Association 2015
Submit a response

Comments

No Comments have been published for this article.